Q1. Describe the estimation of hemoglobin. Discuss the principle, methods used, procedure, normal values, calculation/reporting, sources of error, and automated estimation of Hb. Q2. How is TLC estimated manually and by an automated analyzer? Discuss the principle, diluting fluids, procedure, calculation, normal range, sources of error, and interpretation of leukocytosis/leukopenia. Q3. Describe preparation and examination of a peripheral blood smear. Discuss different stains, staining procedure, differential leukocyte count, RBC/platelet morphology, and automated methods of differential count. Q4. Describe the estimation of ESR. Explain its principle, methods, procedure, normal values, factors affecting ESR, clinical significance, sources of error, and automated ESR methods. Q5. Describe estimation of PCV by microhematocrit method. Discuss the principle, procedure, calculation, normal values, sources of error, interpretation, and automated estimation of hematocrit. Q6. What are RBC indices? Describe MCV, MCH, MCHC and RDW—their formulas, normal values, methods of measurement/calculation, automated determination, and clinical significance. Q7. Describe reticulocyte count. Discuss its principle, supravital stains, procedure, calculation, normal values, corrected reticulocyte count, RPI, clinical significance, and automated reticulocyte counting. Q8. Describe estimation of absolute eosinophil count. Discuss the principle, diluting fluid, procedure, calculation, normal range, causes of eosinophilia/eosinopenia, and automated eosinophil counting. Q9. Describe the laboratory diagnosis of sickling. Discuss the principle and procedure of sickling test, solubility test, controls, interpretation, limitations, and confirmatory tests for sickle hemoglobin. Q10. Describe myeloperoxidase (MPO) cytochemistry. Discuss its principle, reagents, procedure, interpretation, clinical applications, limitations, and comparison with MPO detection by flow cytometry. Q11. Describe platelet counting by manual and automated methods. Discuss the principle, procedure, calculation, normal range, causes of thrombocytopenia/thrombocytosis, pseudothrombocytopenia, and platelet parameters generated by automated analyzers. Q12. Describe complete routine urine examination. Discuss physical, chemical and microscopic examination, principles of common reagent-strip tests, urine sediments, automated urine analyzers, and clinical significance.

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Here are comprehensive answers to all 12 questions, based on standard hematology references (Dacie & Lewis Practical Haematology, Wintrobe's Clinical Hematology, Henry's Clinical Diagnosis and Management by Laboratory Methods, and the Tietz Textbook of Laboratory Medicine).

Q1. Estimation of Hemoglobin

Principle

Hemoglobin (Hb) is the iron-containing oxygen-transport protein of red blood cells. Its estimation exploits the fact that Hb and its derivatives absorb light at specific wavelengths. The internationally recommended cyanmethemoglobin (hemiglobincyanide, HiCN) method converts all Hb forms (except sulfhemoglobin) to the stable colored compound cyanmethemoglobin, which is read spectrophotometrically at 540 nm.

Methods Used

MethodPrincipleStatus
Sahli's acid hematinHCl converts Hb to brown acid hematin; visual color comparisonOutdated; inaccurate
Cyanmethemoglobin (HiCN)All Hb → HiCN by Drabkin's reagent; read at 540 nmGold standard (ICSH recommended)
OxyhemoglobinHb diluted in Na2CO3; read at 540 nmLess accurate (misses MetHb)
Alkaline hematin D-575NaOH converts Hb to alkaline hematin; read at 575 nmDetergent-based; used in automated counters
SLS (Sodium Lauryl Sulfate) HbSLS lyses RBCs; Hb → stable SLS-Hb; read at 540 nmUsed in Sysmex analyzers

Cyanmethemoglobin Method - Procedure

Reagent (Drabkin's solution):
  • Potassium ferricyanide K3[Fe(CN)6]: 200 mg
  • Potassium cyanide (KCN): 50 mg
  • Potassium dihydrogen phosphate (KH2PO4): 140 mg
  • Non-ionic detergent (Sterox/Triton X): 0.5 mL
  • Distilled water to 1000 mL
  • pH 7.0-7.4; stable for months in amber bottle
Procedure:
  1. Pipette 5.0 mL of Drabkin's reagent into a labeled tube
  2. Add 20 µL (0.02 mL) of well-mixed EDTA anticoagulated blood using a calibrated pipette
  3. Mix well; let stand at room temperature for 3-5 minutes (ensures complete conversion)
  4. Read absorbance at 540 nm against a reagent blank in a spectrophotometer
  5. Calculate Hb concentration using calibration curve or standard
Dilution factor: 5.0/0.02 = 251

Normal Values

GroupHemoglobin (g/dL)
Adult male13.5-17.5
Adult female12.0-16.0
Pregnant female≥11.0
Newborn14.0-20.0
Children (6-12 years)11.5-15.5
Elderly male12.0-17.0
WHO criteria for anemia: Hb <13 g/dL (men), <12 g/dL (non-pregnant women), <11 g/dL (pregnant women).

Calculation/Reporting

Using a standard:
Hb (g/dL) = (Absorbance of test / Absorbance of standard) × Concentration of standard (g/dL)
Using Beer-Lambert law with extinction coefficient: Hb (g/dL) = (Absorbance × 1000 × dilution factor) / (44 × 1000)
Where 44 mmol/L is the millimolar extinction coefficient of HiCN at 540 nm.
Report as: Hb = X g/dL (or g/L in SI units, multiply by 10).

Sources of Error

Pre-analytical:
  • Improper mixing of blood before sampling
  • Lipemia/turbid plasma (falsely elevated absorbance)
  • Very high WBC count (>30 × 10⁹/L) causes turbidity
  • Improper blood-to-anticoagulant ratio
Analytical:
  • Incomplete conversion (reading before 3 minutes)
  • Dirty cuvette; fingerprints on optical surfaces
  • Wavelength miscalibration
  • Reagent deterioration (yellowed Drabkin's = discard)
  • Carboxy-hemoglobin (HbCO) converts slowly - wait 10 min in heavy smokers
Instrument errors:
  • Pipetting inaccuracies (most common with Sahli)
  • Failure to zero spectrophotometer properly
HbS, HbC, HbM - all convert to HiCN; only sulfhemoglobin is NOT measured (clinically negligible).

Automated Estimation of Hb

Modern hematology analyzers (Sysmex XN, Abbott CELL-DYN, Beckman Coulter DxH series) measure Hb using the SLS-hemoglobin method or modified alkaline hematin method:
  1. SLS method (Sysmex): Sodium lauryl sulfate lyses RBCs and converts all Hb forms to stable SLS-Hb; measured photometrically at 540 nm. Advantages: no cyanide (environmentally safer), stable reagent.
  2. Impedance + photometric combination: RBC count and Hb measured simultaneously; MCV derived from pulse height; indices calculated automatically.
  3. Direct spectrophotometry at multiple wavelengths to correct for interfering substances.
  4. Quality control: Automated analyzers use 3-level commercial controls (normal, low, high) daily; Levey-Jennings charts and Westgard rules applied. External QA via proficiency testing programs (EQAS).

Q2. Total Leukocyte Count (TLC)

Principle

WBCs are counted in a defined volume of diluted blood using a hemocytometer (manual) or electrical impedance/light scattering (automated). Red cells are lysed by the diluting fluid to leave only leukocytes for counting.

Manual Method

Diluting Fluids

FluidCompositionAction
Turk's fluid (standard)1% glacial acetic acid + 1% aqueous gentian violetAcetic acid lyses RBCs; gentian violet stains WBC nuclei
Dilute HCl (1%)1 mL conc. HCl in 99 mL waterLyses RBCs; WBCs visible but unstained
2% acetic acidSimple alternativeLyses RBCs only

Procedure (Improved Neubauer Hemocytometer)

  1. Mix blood well; draw 0.5 mL Turk's fluid into a WBC pipette (or use appropriate dilution tube)
  2. Add 0.02 mL blood → dilution = 1:20 (or 20 µL blood + 380 µL Turk's = 1:20)
  3. Mix thoroughly for 2-3 minutes (figure-8 rotation if using pipette)
  4. Charge the hemocytometer: touch tip to edge of coverslip and allow capillary action to fill the chamber
  5. Allow cells to settle for 2-3 minutes
  6. Count under 10× objective (low power)
  7. Count WBCs in all 9 large squares (entire grid, but conventionally 4 corner squares + central square = 5 squares, each 1 mm²)
Standard practice: Count WBCs in all 4 corner large squares (each 1 mm × 1 mm × 0.1 mm depth = 0.1 µL per square).

Calculation

WBC/mm³ = (Number of cells counted × Dilution factor) / Volume counted (mm³)
If cells counted in 4 corner squares:
  • Volume = 4 × (1 × 1 × 0.1) = 0.4 mm³
  • WBC/µL = (N × 20) / 0.4 = N × 50
If all 9 squares used:
  • Volume = 9 × 0.1 = 0.9 mm³
  • WBC/µL = (N × 20) / 0.9
Example: 130 cells in 4 squares → TLC = 130 × 50 = 6,500/µL

Normal Range

AgeWBC (×10⁹/L or ×10³/µL)
Adult4.0-11.0
Newborn9.0-30.0
1 year6.0-17.5
4-7 years5.0-15.0
8-12 years4.5-13.5

Sources of Error (Manual)

  • Underfilling/overfilling the hemocytometer chamber
  • Uneven distribution - improper mixing
  • Counting nucleated RBCs as WBCs (correction required: if NRBC seen on smear)
  • Platelet clumps mistaken for WBCs
  • Lysis failure - cells too lysed in acetic acid if left too long
  • Parallax errors - counting cells on boundary lines (count top and left lines only, not bottom and right - the "L rule")
  • Dry edges of chamber - avoid counting peripheral rows
  • Hemocytometer not horizontal during filling - uneven distribution
NRBC Correction Formula: Corrected WBC = (Observed WBC × 100) / (100 + No. of NRBCs per 100 WBCs)

Automated TLC

Modern analyzers use two principles:

1. Electrical Impedance (Coulter Principle)

  • Cells suspended in electrolyte pass through an aperture
  • Each cell displaces electrolyte, causing a change in electrical resistance (pulse)
  • Pulse height ∝ cell volume; pulse frequency = cell count
  • After RBC lysis (by lysing reagent), WBCs counted in impedance channel
  • Separates WBC into 3 populations: lymphocytes (small), mid-cells (monocytes, eosinophils, basophils), granulocytes (large) → 3-part differential

2. Light Scattering (VCS / Flow Cytometry-based)

  • Cells pass through laser beam
  • Forward scatter (FSC) = cell size
  • Side scatter (SSC) = granularity/internal complexity
  • Fluorescence channels (for DNA/RNA staining) separate immature cells
  • 5-part differential: neutrophils, lymphocytes, monocytes, eosinophils, basophils

3. Multi-parameter Analysis (e.g., Sysmex XN-series)

  • Uses multiple channels: WBC/DIFF, RET (reticulocyte), PLT channels
  • Fluorescent dyes label nucleic acids; immature granulocytes (IG), blasts flagged
  • Reports: absolute counts for all 5 types + IG count + atypical lymphocyte flags

Interpretation

Leukocytosis (TLC >11.0 × 10⁹/L in adults)

WBC Type IncreasedCauses
NeutrophiliaBacterial infections, tissue necrosis, steroids, CML, leukemoid reaction, post-splenectomy, burns
LymphocytosisViral infections (EBV, CMV, hepatitis), CLL, ALL, pertussis, toxoplasmosis
MonocytosisTB, subacute bacterial endocarditis, malaria, CMML
EosinophiliaAllergies/asthma, parasitic infestations, drug reactions, Löffler syndrome, CEL
BasophiliaCML, polycythemia vera, myxedema, allergic reactions
Leukemoid reactionTLC >50 × 10⁹/L with left shift - reactive, not neoplastic

Leukopenia (TLC <4.0 × 10⁹/L)

SubtypeCauses
Neutropenia (<1.5 × 10⁹/L)Aplastic anemia, chemotherapy, viral infections (HIV, influenza), megaloblastic anemia, hypersplenism, SLE, Felty syndrome, cyclic neutropenia
LymphopeniaHIV/AIDS, steroids, SLE, Hodgkin's lymphoma, radiation
PancytopeniaAplastic anemia, megaloblastic anemia, bone marrow infiltration

Q3. Peripheral Blood Smear (PBS) - Preparation and Examination

Preparation of Blood Smear

Materials

  • Fresh EDTA blood (within 2 hours) or finger-prick capillary blood
  • Clean, grease-free glass slides (75×25 mm)
  • Spreader slide (edges polished or with 45° angle)

Wedge (Push) Method - Standard Procedure

  1. Place a small drop (2-3 µL) of blood 1 cm from one end of the slide
  2. Hold the spreader slide at 30-45° angle in front of the blood drop
  3. Draw spreader back to touch the blood drop; allow blood to spread along the edge by capillary action
  4. Push the spreader forward in one smooth, even, rapid stroke
  5. The smear should be 2-3 cm long, with a feathered tail and central body (not touching edges)
  6. Air dry immediately (wave the slide or use fan); do not heat-fix

Features of a Good Smear

  • Gradual transition from thick (head) to thin (tail/feathered edge)
  • No holes, streaks, or ridges
  • Occupies 2/3 of the slide length
  • RBCs just separate at the feathered edge
  • Body of smear: slight overlapping; counting area: single-cell layer

Common Errors in Preparation

ErrorCause
Too thickDrop too large; spreader angle too steep; slow push
Too thinDrop too small; angle too shallow; fast push
Ridged/irregularDirty slide; debris on spreader edge
Too shortDry slide; blood drawn back before spreading
Holes in smearLipemia; silicone gloves; dirty slide

Staining Methods

1. Romanowsky Stains (Gold Standard)

All Romanowsky stains contain acidic eosin (stains basic components red-pink) and basic methylene blue or azure B (stains acidic components blue-purple). The combination gives a specific Romanowsky effect - purple staining of chromatin.
a) Leishman's Stain
  • Contains: Leishman's powder (eosin + methylene blue) in absolute methanol
  • Methanol: fixes and stains simultaneously
  • Procedure:
    1. Flood air-dried smear with Leishman's stain for 2 minutes (fixation)
    2. Add equal volume of buffered water (pH 6.8) for 10-15 minutes
    3. Wash with buffered water; drain; air dry; do not blot
  • Result: RBCs - pink/red; WBC nuclei - blue/purple; neutrophil granules - pink-purple; eosinophil granules - bright red; basophil granules - deep purple; platelets - purple granules
b) Giemsa Stain
  • May-fix separately in methanol, then stain in 10% Giemsa (pH 7.2) for 20-30 minutes
  • Excellent for parasites (malaria, trypanosomes) and lymphoid cells
  • Often used as May-Grünwald-Giemsa (MGG) combination
c) Wright's Stain
  • Most common in North America
  • Fixed and stained simultaneously in Wright's stain (methanol-based)
  • Procedure: flood 1-3 min, add buffer, stain 10-15 min, rinse
d) Field's Stain
  • Rapid, 2-solution method for thick malaria films
  • Solution A (basic) + Solution B (acidic); dip 1-2 seconds each
  • Not suitable for detailed morphology

Staining Defects and Causes

DefectCause
Too blueThick smear; over-stained; alkaline buffer/water; prolonged staining
Too pinkUnderstained; acidic buffer; prolonged washing
Precipitate on smearDirty slide; stain filtered inadequately; stain dried on slide
Pale/washed outOld stain; over-washing

Examination Sequence

  1. Macroscopic: Check smear quality (good/acceptable/poor)
  2. Low power (10×): Overall cellularity, assess area for counting, look for large cells/parasites
  3. High power / Oil immersion (100×): Detailed morphology

Differential Leukocyte Count (DLC)

Count minimum 100 cells (200 for accuracy) in the counting area (monolayer zone, just behind feathered edge) using a systematic zigzag/battlement pattern.

Normal DLC (Adults)

Cell TypePercentageAbsolute Count (×10⁹/L)
Neutrophils (segmented)50-70%2.0-7.5
Lymphocytes20-40%1.0-4.5
Monocytes2-10%0.2-1.0
Eosinophils1-4%0.04-0.5
Basophils0-1%0-0.1
Band (stab) forms0-5%0-0.5

Neutrophil Features

  • Segmented: 2-5 lobes connected by thin filaments; pink cytoplasm; azurophilic (primary) granules + specific (secondary) granules
  • Band form: Horse-shoe nucleus; no filament visible (lobe > 1/3 width)
  • Hypersegmentation: >5 lobes; seen in megaloblastic anemia
  • Left shift: Increased band forms, metamyelocytes, myelocytes on smear (infection, leukemoid reaction, CML)

RBC Morphology Assessment

ParameterNormalAbnormality
Size7-8 µmMicrocytes (<6 µm), Macrocytes (>9 µm), Anisocytosis
ShapeBiconcave discPoikilocytosis - see below
ColorNormochromic (pale area = 1/3)Hypochromia, Hyperchromia, Polychromasia
DistributionNormocytic, not aggregatedRouleaux, Agglutination

Key Poikilocytes and Their Significance

PoikilocyteSignificance
Sickle cell (drepanocyte)Sickle cell disease
Target cell (codocyte)Thalassemia, HbC, liver disease, post-splenectomy
SpherocyteHereditary spherocytosis, AIHA
Elliptocyte/ovalocyteHereditary elliptocytosis
Schistocyte/helmet cellMicroangiopathic hemolytic anemia (TTP, HUS, DIC)
Tear-drop cell (dacrocyte)Myelofibrosis, thalassemia
Acanthocyte (spur cell)Abetalipoproteinemia, liver disease
Echinocyte (burr cell)Uremia, pyruvate kinase deficiency, artefact
StomatocyteHereditary stomatocytosis, alcoholism
Bite cellG6PD deficiency

Platelet Morphology on Smear

  • Normal platelets: 1.5-3.5 µm; pale blue with central purple granules (2-4/oil immersion field)
  • Giant platelets (megathrombocytes): ITP, MYH9 disorders, CML, myeloproliferative neoplasms
  • Platelet clumps: EDTA-induced pseudothrombocytopenia; use citrate tube or warm blood
  • Platelet satellitism: Platelets clustering around neutrophils; cause of spurious neutrophilia
  • Hypogranular platelets: Myelodysplastic syndrome, grey platelet syndrome
Estimate of platelet count from smear: Average platelets/oil field × 15,000 = approximate platelet count/µL (Normal: 8-20 platelets per 100× oil immersion field)

Automated Differential Count

Automated analyzers perform DLC using:
  1. 3-part differential (older analyzers): Impedance only; separates lymphocytes, mid-cells, granulocytes (not useful for individual 5-part DLC)
  2. 5-part differential:
  • VCS technology (Beckman Coulter): Volume (V) by DC impedance, Conductivity (C) by RF, Scatter (S) by laser - gives 5-population separation
  • Flow cytometry-based (Sysmex): Fluorescent dye (polymethine/oxazine) + forward/side scatter; separate neutrophils, lymphocytes, monocytes, eosinophils, basophils with flags for blasts/atypical lymphs/IG (immature granulocytes)
  • Abbott CELL-DYN Sapphire: 4-angle light scatter + fluorescence
  1. Digital morphology systems (CellaVision DM96, Morphogo):
  • High-resolution image capture of blood smear
  • AI/neural network classifies cells automatically with human review
  • Excellent for morphology documentation and educational use
  1. Limitations of automated DLC:
  • Cannot reliably identify atypical/reactive lymphocytes, blasts, dysplastic cells
  • All flagged/abnormal samples require manual microscopy review
  • ICSH recommends microscopy review criteria (>1% blasts, flags, clinical context)

Q4. Erythrocyte Sedimentation Rate (ESR)

Principle

When anticoagulated blood is placed in a vertical tube, RBCs sediment under gravity. The rate is influenced by plasma proteins (especially fibrinogen and globulins) that reduce the negative surface charge of RBCs (zeta potential), promoting rouleaux formation. Rouleaux (coin-stack aggregates) sediment faster than individual RBCs because the mass-to-surface ratio is increased.
Three stages:
  1. Lag phase (10 min): Initial rouleaux formation; little sedimentation
  2. Sedimentation phase (40 min): Constant, rapid settling
  3. Packing phase (10 min): Slowing as RBCs pack at bottom
ESR = height of clear plasma column above packed RBCs at 1 hour (mm/hr)

Methods

1. Westergren Method (ICSH/WHO Recommended)

  • Anticoagulant: Trisodium citrate 3.8% (1 part + 4 parts blood = 1:4 ratio; 0.5 mL citrate + 2.0 mL blood) OR EDTA blood diluted 4:1 with citrate/saline
  • Tube: Westergren tube - length 300 mm, internal bore 2.55 mm, graduated 0-200 mm
  • Procedure:
    1. Mix blood well with citrate; fill Westergren tube to 0 mark by suction
    2. Place vertically in Westergren stand at room temperature (18-25°C)
    3. Read the level of clear plasma at exactly 1 hour (read from top - 0 mark downward)
    4. Report as mm in 1st hour

2. Wintrobe Method

  • Anticoagulant: EDTA or double oxalate blood (no dilution)
  • Tube: Wintrobe tube - 110 mm long, 3 mm bore, graduated 0-10 cm
  • Fill to 0 mark; read at 1 hour
  • Less sensitive than Westergren; also used for PCV simultaneously
  • Normal values lower than Westergren

3. Micro-ESR (Pediatric)

  • Uses capillary blood; Landau tube (75 mm); read at 1 hour

Normal Values

MethodMaleFemale
Westergren0-15 mm/hr0-20 mm/hr
Wintrobe0-9 mm/hr0-20 mm/hr
Newborns0-2 mm/hr-
Children3-13 mm/hr-
Elderly (>60 yr)Up to 20 mm/hrUp to 30 mm/hr

Factors Affecting ESR

Factors That Increase ESR

Plasma factors (most important):
  • Fibrinogen (most potent rouleaux promoter)
  • Immunoglobulins (IgG, IgM, IgA)
  • Alpha-2 globulins, acute phase proteins (CRP, haptoglobin)
  • Paraproteinemia (myeloma)
RBC factors:
  • Anemia (fewer RBCs = less hindrance to sedimentation)
  • Macrocytosis (larger RBCs form better rouleaux)
Technical/physiological:
  • Female sex (higher fibrinogen)
  • Pregnancy (increased fibrinogen; ESR not useful in pregnancy)
  • Obesity
  • Temperature increase

Factors That Decrease ESR

  • Polycythemia (high RBC mass - steric hindrance)
  • Sickle cell disease (abnormal shape impedes rouleaux)
  • Hereditary spherocytosis (spheres don't form rouleaux)
  • Hypofibrinogenemia/DIC
  • Hyperviscosity (paradoxically slows settling)
  • Low temperature
  • Congestive cardiac failure (reduced fibrinogen)

Technical Errors That Increase ESR

  • Tube not perfectly vertical (even 3° tilt increases ESR by 30%)
  • Blood-to-citrate ratio error (wrong dilution)
  • Prolonged delay (>2 hours from collection)
  • Room temperature >25°C

Technical Errors That Decrease ESR

  • Clotted/hemolyzed sample
  • Improper filling (below 0 mark)
  • Cold temperature

Clinical Significance

DegreeValueCauses
Mild elevation20-40 mm/hrInfections, anemia, pregnancy, aging
Moderate40-70 mm/hrActive infection, connective tissue disease, malignancy
High>100 mm/hrMultiple myeloma, temporal arteritis, nephrotic syndrome, TB, malignancy, rheumatoid arthritis (active)
Very high>120 mm/hrMultiple myeloma (classic), bacterial endocarditis, polymyalgia rheumatica
Normal ESR largely excludes: temporal arteritis and polymyalgia rheumatica (high sensitivity).
ESR is a non-specific test - elevated in any inflammatory state; used for:
  • Monitoring disease activity (SLE, RA, IBD)
  • Screening for occult disease
  • Distinguishing organic from functional disease

Automated ESR Methods

  1. TEST 1 System (Greiner Bio-One): Photometric measurement of RBC column at multiple time points; ESR reported in Westergren-equivalent values; results in 20-30 minutes
  2. Alifax RED system: Laser-based optical aggregometry; measures kinetics of RBC aggregation in capillary tubes; fast result (20 sec)
  3. ISOCOMP analyzer: Thermostatic control; corrects for temperature variations
  4. Ves-Matic (Menarini): Infrared sensor tracks sedimentation; provides final Westergren-equivalent
Advantages of automated systems: faster results, smaller sample volume, reduced operator bias, temperature correction, traceability.

Q5. Packed Cell Volume (PCV) / Hematocrit - Microhematocrit Method

Principle

When blood is centrifuged, cells are packed at the bottom and plasma remains on top. PCV (hematocrit) is the fraction of total blood volume occupied by red blood cells. The microhematocrit method uses a high-speed microcentrifuge with capillary tubes to achieve rapid, accurate results.

Procedure

Equipment

  • Heparinized capillary tubes (red band at one end) - for EDTA blood or plain for fresh capillary blood
  • Plain capillary tubes (blue band) - for capillary blood (heparinized)
  • Microcentrifuge (12,000-15,000 rpm; radius ~8 cm)
  • Reading card/chart or special PCV reader

Steps

  1. Fill capillary tube 2/3 to 3/4 full with well-mixed EDTA blood by capillary action (hold at 45° angle in blood)
  2. Seal the dry end with Cristaseal (plasticine/sealant) - apply flat to seal completely
  3. Place in microcentrifuge with sealed end toward the periphery (outward)
  4. Balance the centrifuge (pairs of tubes diametrically opposite)
  5. Centrifuge at 12,000-15,000 rpm for 5 minutes
  6. Read PCV using the reading chart immediately (before the buffy coat disperses)

Reading

  • Total blood column (from inside of seal to top of plasma)
  • RBC column height
  • PCV = Red cell column height / Total blood column height
  • Read from the reading card: align bottom of red cell column with 0, top of plasma with 100, read off % at top of red cell column
  • Do NOT include buffy coat in the red cell column (buffy coat = WBCs + platelets, appears as grey-white layer above RBCs)

Normal Values

GroupPCV (%)PCV (L/L)
Adult male40-54%0.40-0.54
Adult female36-47%0.36-0.47
Newborn44-64%0.44-0.64
1 year30-40%0.30-0.40
Children35-45%0.35-0.45
Elderly male37-51%0.37-0.51
Polycythemia: PCV >54% (male), >47% (female) Anemia (severe): PCV <25%

Calculation

Relationships with other indices:
  1. Hb (g/dL) ≈ PCV (%) / 3 (rough estimate; Hb × 3 = PCV)
  2. MCV (fL) = (PCV/L/L × 1000) / RBC (×10¹²/L)
  3. MCHC (g/dL) = Hb (g/dL) / PCV (L/L)

Sources of Error

False High PCV

  • Trapped plasma: Incomplete centrifugation; high MCV (macrocytes trap more plasma); sickle cells and irregularly shaped cells trap plasma (up to 2-3% error); microhematocrit has ~1-2% trapped plasma
  • Polycythemia (genuine)
  • Blood from IV line with fluid contamination
  • Including buffy coat in reading

False Low PCV

  • Overcoagulation (excess EDTA causes RBC shrinkage - water shifts out) - most important error
  • Over-centrifugation (partial hemolysis)
  • Hemolysis (lysis of RBCs reduces their volume)
  • Reading before spin complete

Other Errors

  • Capillary tube not sealed properly → blood expelled
  • Air bubbles in tube
  • Prolonged storage before centrifugation (glucose consumption, cell swelling)
  • Tilted centrifuge

Interpretation

  • High PCV: Polycythemia vera, secondary polycythemia (altitude, COPD, EPO-secreting tumors), dehydration (relative polycythemia)
  • Low PCV: Anemia (all causes), overhydration, dilutional anemia of pregnancy

Automated Estimation of Hematocrit

Modern analyzers calculate (not measure directly) hematocrit:
Hct = MCV × RBC count / 10
Where MCV is derived from pulse height histogram of impedance counter, and RBC count from pulse counting.
Advantages: Eliminates trapped plasma error; faster; uses same blood sample as other CBC parameters.
Note: The calculated Hct is consistently 1-3% lower than centrifuged PCV (because centrifuge traps some plasma).

Q6. RBC Indices

Red cell indices are derived values that describe the size and hemoglobin content of red blood cells. They are used to classify anemias.

MCV - Mean Corpuscular Volume

Definition: Average volume of a single red blood cell.
Formula:
MCV (fL) = PCV (L/L) × 1000 / RBC count (×10¹²/L)
Or equivalently: MCV = (Hematocrit × 10) / RBC (millions/µL)
Normal value: 80-100 fL (femtoliters)

Classification by MCV

MCVClassificationCauses
<80 fLMicrocyticIron deficiency anemia, thalassemia, sideroblastic anemia, anemia of chronic disease (sometimes)
80-100 fLNormocyticAcute blood loss, hemolytic anemia, aplastic anemia, anemia of chronic disease, mixed deficiency
>100 fLMacrocyticMegaloblastic anemia (B12/folate deficiency), hypothyroidism, liver disease, alcoholism, drugs (hydroxyurea, methotrexate)

Automated Measurement of MCV

In impedance analyzers, each RBC generates a voltage pulse proportional to its volume. The MCV is the mean of the pulse height histogram - the average of all individual cell volumes. This is extremely accurate (CV <1%) and is the most reproducible parameter in CBC.

MCH - Mean Corpuscular Hemoglobin

Definition: Average mass of hemoglobin in a single RBC.
Formula:
MCH (pg) = Hb (g/dL) × 10 / RBC count (×10¹²/L)
Normal value: 27-32 pg (picograms)

Clinical Significance

  • Low MCH (<27 pg): Microcytic hypochromic anemia (iron deficiency, thalassemia, sideroblastic)
  • High MCH (>32 pg): Macrocytic anemias (megaloblastic); also in hereditary spherocytosis (spherocytes have high MCHC/MCH despite small size)
  • MCH closely parallels MCV; rarely gives independent information beyond MCV

Automated Calculation

Calculated automatically from Hb and RBC count measured on the analyzer. Not directly measured.

MCHC - Mean Corpuscular Hemoglobin Concentration

Definition: Average concentration of hemoglobin in a given volume of packed RBCs.
Formula:
MCHC (g/dL) = Hb (g/dL) / PCV (L/L) OR: MCHC = (MCH/MCV) × 100
Normal value: 32-36 g/dL (or 320-360 g/L)

Clinical Significance

  • Low MCHC (<32 g/dL): Hypochromia - Iron deficiency anemia (most common cause), thalassemia
  • High MCHC (>36 g/dL): Hyperchromia - Classically seen in hereditary spherocytosis (spherocytes lack central pallor due to reduced surface:volume ratio); also in sickle cell disease
  • MCHC is physiologically constrained (max ~38 g/dL as Hb precipitates above this); any MCHC >38 g/dL = flag as error (lipemia, cold agglutinins, hemolysis in sample → falsely high Hb without proportional rise in RBC/PCV)
  • Very low MCHC in combination with low MCV = strong indicator of iron deficiency

Automated Calculation

Calculated from Hb and calculated hematocrit. In some modern analyzers (Siemens ADVIA), MCHC is directly measured using the relationship between hemoglobin content (measured by cyanmethemoglobin equivalent) and cell volume (measured by light scatter).

RDW - Red Cell Distribution Width

Definition: A measure of the variation in RBC size (anisocytosis); the coefficient of variation of the RBC volume distribution.
Formula:
RDW-CV (%) = (Standard deviation of MCV / Mean MCV) × 100
Also reported as RDW-SD (standard deviation of the RBC volume histogram in fL).
Normal value (RDW-CV): 11.5-14.5%

Clinical Significance

RDWMCVInterpretation
HighLowIron deficiency anemia (earliest change: RDW rises before MCV falls), mixed deficiency
NormalLowThalassemia trait (uniform microcytosis; RDW usually normal)
HighNormalEarly iron/B12/folate deficiency; sickle cell trait; microangiopathic HA
NormalNormalAnemia of chronic disease, acute blood loss
HighHighMegaloblastic anemia, B12/folate deficiency
NormalHighAplastic anemia, liver disease, hypothyroidism
Dimorphic picture (high RDW + bimodal histogram): Post-transfusion, treatment of iron/B12 deficiency, sideroblastic anemia (two populations: normal + hypochromic microcytes)
Key differentiator: Iron deficiency vs. thalassemia trait:
  • Iron deficiency: RDW HIGH + low MCV
  • Thalassemia trait: RDW NORMAL + low MCV (Mentzer index = MCV/RBC count; <13 = thalassemia, >13 = iron deficiency)

Automated Determination

The RDW is directly derived from the RBC volume histogram generated by the impedance counter. The analyzer plots RBC volume on the x-axis and frequency on the y-axis; RDW-CV is the standard deviation/mean × 100.

Summary Table of RBC Indices

IndexFormulaNormalAutomated Method
MCVPCV×1000/RBC80-100 fLMean of pulse height histogram
MCHHb×10/RBC27-32 pgCalculated from Hb + RBC
MCHCHb/PCV32-36 g/dLCalculated; some analyzers measure directly
RDW-CVSD/MCV×10011.5-14.5%SD of RBC histogram

Q7. Reticulocyte Count

Principle

Reticulocytes are immature RBCs that retain residual ribosomal RNA (rRNA) after losing the nucleus during enucleation. This RNA is not visible on Romanowsky stains. Supravital stains (applied to living cells, not fixed) precipitate and stain the RNA as a network of blue threads or granules (the reticulum), making reticulocytes identifiable under light microscopy.
The reticulocyte count reflects the rate of erythropoiesis - it rises when the bone marrow is stimulated (hemolytic anemia, post-hemorrhage, treatment response) and falls in hypoproliferative states (aplastic anemia, megaloblastic anemia before treatment).

Supravital Stains

StainFeatures
New Methylene Blue (NMB)Most reliable; deep blue reticulum; also stains HbH inclusions (multiple dots in alpha thalassemia) and Heinz bodies; ICSH recommended
Brilliant Cresyl Blue (BCB)Also common; bright blue reticulum on green-tinged background
Acridine orangeFluorescent supravital stain; used in automated methods

Procedure (Manual - New Methylene Blue)

  1. Mix equal volumes of blood and NMB stain solution (0.5 mL each) in a small tube
  2. Incubate at 37°C for 15-20 minutes (or room temperature for 30 min)
  3. Make thin films from the mixture; air dry
  4. Optionally, counterstain with Leishman's for 1-2 min (for better background)
  5. Examine under oil immersion (100×)
Counting:
  • Count 1000 RBCs; note cells with blue reticulum (≥2 granules counts as reticulocyte per ICSH)
  • Alternative: Count reticulocytes in each field, count until 1000 RBCs total
Classification (Miller's):
  • Class I: Dense clump/network
  • Class II: >3 granules, no clump
  • Class III: 2-3 granules
  • Class IV: 1 granule (NOT a reticulocyte by ICSH criteria)

Normal Values

GroupReticulocyte Count (%)Absolute Count (×10⁹/L)
Adult0.5-2.5%25-100 × 10⁹/L (50-100 × 10⁹/L)
Newborn (1st week)2-6% (higher)Physiologically elevated
Children0.5-2.0%
Absolute reticulocyte count (ARC):
ARC = Reticulocyte % × RBC count (×10¹²/L) × 10
Normal ARC = 50-100 × 10⁹/L; more reliable than % in anemia.

Corrected Reticulocyte Count (CRC)

Since anemia itself increases % reticulocytes (fewer RBCs = fewer denominator cells), the count is corrected for degree of anemia:
CRC (%) = Reticulocyte % × (Patient PCV / Normal PCV) Normal PCV used: 0.45 (45%)
Interpretation of CRC:
  • CRC >3% = Hyperproliferative marrow (hemolytic anemia, blood loss, treatment response)
  • CRC <2% = Hypoproliferative marrow (iron/B12 deficiency, aplastic anemia, marrow infiltration)

Reticulocyte Production Index (RPI)

CRC further corrected for "shift" reticulocytes (early release of reticulocytes from marrow in severe anemia - these circulate for longer before maturing):
RPI = CRC / Maturation factor
Patient PCVMaturation Factor (days)
45%1.0
35%1.5
25%2.0
15%2.5
Interpretation:
  • RPI >3 = Adequate marrow response (hyperproliferative)
  • RPI <2 = Inadequate marrow response (hypoproliferative)
  • RPI 2-3 = Borderline/equivocal

Clinical Significance

Reticulocytosis (↑)Reticulocytopenia (↓)
Hemolytic anemiaAplastic anemia
Acute blood loss (peak 7-10 days)Iron/B12/folate deficiency (before treatment)
Treatment of deficiency anemias (reticulocyte crisis at 7-10 days)Bone marrow infiltration (leukemia, myeloma)
Polycythemia veraAnemia of chronic disease (relative)
Thalassemia majorChemotherapy/radiation
Sickle cell crisis (post-crisis)Parvovirus B19 (pure red cell aplasia)

Automated Reticulocyte Counting

Modern analyzers count reticulocytes with far greater precision (counting 10,000+ cells vs. 1000 manually, CV <2% vs. >25% manually).
Methods:
  1. Thiazole orange (Sysmex, Beckman Coulter): Fluorescent dye stains RNA; reticulocytes fluoresce more than mature RBCs; laser excitation; fluorescence intensity proportional to RNA content
  2. Oxazine 750 + polymethine (Sysmex RET channel): Stain RNA; cells classified by fluorescence level
Parameters reported:
  • %Reticulocytes and Absolute reticulocyte count
  • IRF (Immature Reticulocyte Fraction): Fraction of highly fluorescent (RNA-rich) reticulocytes = reflects most recent marrow output; rises earliest in erythropoietic stimulation
  • LFR, MFR, HFR: Low, medium, high fluorescence reticulocytes
  • RBC/Retic histograms
Automated advantages: Higher precision, counts all reticulocyte classes, provides IRF, unaffected by operator fatigue, fully automated.

Q8. Absolute Eosinophil Count (AEC)

Principle

Eosinophils are selectively stained or preserved while other cells are lysed, allowing direct counting in the hemocytometer. The diluting fluid lyses RBCs and most WBCs, leaving eosinophils identifiable by their characteristic staining.

Diluting Fluids

FluidCompositionAction
Dunger's fluidEosin 1% aqueous + acetoneEosin stains eosinophil granules orange-red; acetone lyses RBCs; WBC nuclei ghost
Pilot's fluidSodium carbonate 10% + eosin 1%Alkaline solution lyses RBCs; eosinophil granules stained red
Randolph's fluidPropylene glycol 50 mL + distilled water 40 mL + eosin Y 0.1 g + hematoxylin 0.1 g + Na2CO3 1 gBest preservation of eosinophils
Modified Randolph's fluidMost commonly used currently
Dunger's fluid is most commonly used in routine practice.

Procedure

  1. Mix blood well; take 0.38 mL Dunger's fluid in a small tube (or use WBC pipette)
  2. Add 0.02 mL (20 µL) blood → dilution 1:20
  3. Mix gently for 5 minutes (do not over-shake as it may lyse eosinophils)
  4. Charge the improved Neubauer hemocytometer
  5. Allow to settle for 5 minutes (eosinophils take longer to settle)
  6. Count eosinophils in both chambers (both rulings of the hemocytometer)
  7. Count all 9 large squares in both chambers = 18 squares total
    • Volume = 18 × 0.1 mm³ = 1.8 mm³

Calculation

AEC/µL = (Cells counted × Dilution factor) / Volume counted
  • = (N × 20) / 1.8 = N × 11.1
If counting both chambers (18 large squares): AEC/µL = Total eosinophils in 18 squares × 11.1
Alternatively (common exam formula): If N = total eosinophils in both chambers (18 squares): AEC = N × 20 / 1.8 = N × 11.1

Normal Range

  • Normal AEC: 40-440 cells/µL (0.04-0.44 × 10⁹/L)
  • Some sources: 100-400/µL (0.1-0.4 × 10⁹/L)

Causes of Eosinophilia (AEC >500/µL or >0.5 × 10⁹/L)

NAACP Mnemonic:

  • N - Neoplastic: CML, lymphoma (Hodgkin's), eosinophilic leukemia (CEL), myeloproliferative neoplasms
  • A - Allergic/Atopic: Asthma, allergic rhinitis, urticaria, atopic dermatitis
  • A - Addison's disease (adrenocortical insufficiency)
  • C - Collagen vascular/autoimmune: Polyarteritis nodosa, eosinophilic granulomatosis with polyangiitis (Churg-Strauss), SLE, dermatomyositis
  • P - Parasites: Intestinal (Ascaris, hookworm, Toxocara) and tissue-invasive parasites (Trichinella, Toxocara, Filaria, Schistosoma) especially those with tissue-invasive phase
Other causes: Löffler syndrome, tropical eosinophilia, drug reactions (aspirin, penicillin, sulfonamides), hypereosinophilic syndrome (HES; AEC persistently >1500/µL), Kimura disease, DRESS syndrome.

Eosinophilia Classification by Severity:

  • Mild: 500-1500/µL
  • Moderate: 1500-5000/µL
  • Severe/Hypereosinophilic: >5000/µL (risk of organ damage: cardiac Löffler endocarditis, neuropathy)

Causes of Eosinopenia (AEC <40/µL)

  • Cushing's syndrome / exogenous corticosteroids (steroids cause eosinophil sequestration in tissues)
  • Acute bacterial infections (cortisol response)
  • Post-surgery, acute stress
  • Typhoid fever (classic: eosinopenia a feature)
  • Excess ACTH stimulation
Thorn test (historical): ACTH or cortisone injection should cause ≥50% reduction in AEC at 4 hours - used to test adrenal function; positive if no reduction = adrenal insufficiency. Now obsolete.

Automated Eosinophil Counting

Modern 5-part differential analyzers identify eosinophils reliably:
  • Sysmex: Eosinophils identified in WBC/DIFF channel by their characteristic high side-scatter (large, refractile granules) + intermediate fluorescence; also the "EO" channel uses ammonium chloride-based lysis
  • Beckman Coulter DxH: VCS technology - eosinophils have distinct conductivity signature due to large granule content
  • Abbott CELL-DYN: 4-angle scatter; eosinophil granules give unique 90° depolarized light scatter
Automated AEC is now preferred over manual counting in most labs (higher precision, CV ~3-5% vs. 15-25% for manual; counting 5,000-10,000 cells).
However, manual AEC remains important when:
  • Automated analyzer not available
  • Verifying automated count when eosinophilia suspected on smear
  • Counting after automated flags

Q9. Laboratory Diagnosis of Sickling

Sickling Test (Sodium Metabisulfite Test)

Principle

HbS polymerizes when deoxygenated, forming long fibers (tactoids) that distort the RBC into a sickle/crescent shape. Sodium metabisulfite (Na₂S₂O₅) is a reducing agent that creates an anoxic (deoxygenated) environment, inducing sickling in cells containing HbS. Cells containing only HbA do not sickle.

Reagents

  • Fresh sodium metabisulfite solution (2%): 200 mg Na₂S₂O₅ dissolved in 10 mL distilled water; must be freshly prepared for each test session (deteriorates within 4 hours)

Procedure

  1. Place 1 drop of 2% fresh sodium metabisulfite on a glass slide
  2. Add 1 drop of blood; mix well
  3. Cover with a sealed coverslip (seal all edges with nail varnish/petroleum jelly to maintain anoxia)
  4. Incubate at room temperature for 30 minutes to 1 hour (some protocols: examine at 1 hour and again at 24 hours)
  5. Examine under low power (10×) and high power (40×)

Interpretation

  • Positive: Presence of sickle-shaped (crescent), oat-shaped, or holly-leaf shaped cells = HbS present
  • Negative: All cells remain disc-shaped
  • Rate: Most sickle cells by 1 hour; sensitivity improves with longer incubation

Controls

  • Positive control: Known sickle cell blood (HbSS)
  • Negative control: Normal blood (HbAA)
  • Positive and negative controls must be run with every batch

Solubility Test (Sickledex / Itano Solubility Test)

Principle

HbS (deoxygenated) is insoluble in a high-molarity phosphate buffer, forming a turbid suspension (tactoids precipitate). All other hemoglobins (HbA, HbF, HbC, HbE, etc.) remain soluble and give a clear solution.

Procedure

  1. Add 2 mL sodium dithionite (Na₂S₂O₄) reducing solution (high phosphate buffer + saponin for hemolysis)
  2. Add 20 µL fresh blood
  3. Mix and allow to react for 5 minutes at room temperature
  4. Examine turbidity: Hold tube in front of a ruled card/paper

Interpretation

  • Positive (turbid): Cannot read the lines through the tube = HbS present (sickle cell trait OR disease)
  • Negative (clear): Lines clearly visible = HbS absent

Advantages and Limitations

  • Advantages: Simple, rapid, no microscopy needed, good screening test
  • Limitations:
    • Does not distinguish HbSS from HbAS (trait vs. disease)
    • False positives: Very high WBC count (>50 × 10⁹/L), very high Hb (polycythemia), lipemia, cord blood (HbF)
    • False negatives: Anemia (Hb <7 g/dL - insufficient HbS to cause turbidity), infants <6 months (high HbF), recent transfusion (dilution with HbA)
    • Does not detect other sickling hemoglobins (HbC, HbD, HbO-Arab) unless combined with HbS

Comparison of Tests

FeatureSickling TestSolubility Test
PrincipleMorphological sicklingTurbidimetry
DetectsHbS presentHbS present
Distinguishes HbSS/HbASNoNo
Sensitivity~90%~95%
Time1-24 hours5 minutes
CostVery cheapCheap
False negativesInfants <6 monthsAnemia

Confirmatory Tests for Sickle Hemoglobin

1. Hemoglobin Electrophoresis (Gold Standard)

Cellulose Acetate Electrophoresis (Alkaline pH 8.6):
  • HbA: Most anodal
  • HbS: Migrates less than HbA (slower)
  • HbC, HbE, HbO-Arab: Co-migrate with each other at alkaline pH
  • HbF: Migrates between HbA and HbS
Citrate Agar Electrophoresis (Acid pH 6.0-6.2):
  • Separates hemoglobins that co-migrate at alkaline pH
  • HbS ≠ HbD, HbG (D and G migrate like A at acid pH)
  • Complementary to alkaline electrophoresis
  • HbS gives a characteristic pattern UNIQUE to acid electrophoresis
Both techniques together: Can identify virtually all common hemoglobinopathies.

2. High-Performance Liquid Chromatography (HPLC) - Bio-Rad Variant II

  • Currently the gold standard in many labs
  • Separates Hb fractions by ion-exchange chromatography
  • Reports retention time and % for each fraction
  • Identifies HbA, HbA2, HbF, HbS, HbC, HbE, HbD and rare variants
  • HbS: Retention time ~4.4 min (on Variant II program); HbA2 measured accurately
  • Also used for neonatal screening

3. Isoelectric Focusing (IEF)

  • Separates Hb by isoelectric point
  • High resolution; used in neonatal screening programs

4. DNA Analysis

  • PCR-based mutation detection for definitive diagnosis, especially in neonatal/prenatal diagnosis
  • Detects specific GAG→GTG mutation at codon 6 of β-globin gene

5. Peripheral Blood Smear

  • HbSS: Sickle cells, target cells, polychromasia, nucleated RBCs
  • HbAS: Occasional target cells; sickle cells rare on routine smear

Q10. Myeloperoxidase (MPO) Cytochemistry

Principle

Myeloperoxidase (MPO) is an enzyme present in the primary (azurophilic) granules of myeloid cells (neutrophils, eosinophils, monocytes). It catalyzes the oxidation of a colorless chromogen (hydrogen donor) by hydrogen peroxide (H₂O₂), producing a colored, insoluble precipitate at the site of enzyme activity:
H₂O₂ + Chromogen → Colored precipitate (MPO-catalyzed)
The precipitate marks the location of MPO-containing granules. This reaction identifies cells of myeloid lineage and distinguishes acute myeloid leukemia (AML) from acute lymphoblastic leukemia (ALL), where MPO is absent.

Reagents (Kaplow Method - Most Common)

  1. Buffered formalin acetone (fixative): 100 mL citrate buffer (pH 6.6) + 10 mL formaldehyde + 90 mL acetone; fix fresh air-dried smears for 30 seconds at 4°C (cold fixation preserves MPO)
  2. Incubation medium:
    • Benzidine dihydrochloride (1%) - chromogen (but carcinogenic; largely replaced)
    • Alternative chromogen: 3,3'-diaminobenzidine (DAB) or naphthol ASD chloroacetate
    • Hydrogen peroxide 0.3%
    • Giemsa stain (counterstain)
  3. Modified method using 3-amino-9-ethylcarbazole (AEC) as chromogen (produces red precipitate)

Sudan Black B (SBB) - Related Stain

  • Not an enzyme stain but stains phospholipids in myeloid granules (similar distribution to MPO)
  • More sensitive than MPO for myeloid differentiation; detects cells where MPO may be denatured
  • Produces black precipitate in myeloid cells

Procedure (Kaplow MPO)

  1. Prepare fresh blood/bone marrow smears; air dry (do NOT heat fix)
  2. Fix in buffered formalin-acetone at 4°C for 30 seconds
  3. Rinse with distilled water; air dry
  4. Immerse in incubation medium (benzidine/DAB + H₂O₂ + buffer) for 30 seconds to 1 minute
  5. Rinse with distilled water
  6. Counterstain with Giemsa for 1-2 minutes
  7. Rinse, air dry, mount with DPX, examine under oil immersion

Interpretation

Cell TypeMPO ResultColor (DAB)
Neutrophils (mature + immature)Strongly positiveBrown granules
EosinophilsStrongly positive (most positive cell)Brown
BasophilsNegative (important! Basophil granules inhibit MPO)
MonocytesWeakly positive (scattered granules)Faint brown
Mast cellsNegative
ALL blastsNegativeNo staining
AML blasts (M1, M2, M3, M4)Positive (≥3% blasts)Brown
AML M5 (monocytic)Weakly positive or negative (use NSE instead)
AML M6, M7Negative
LymphocytesNegative
Plasma cellsNegative
Scoring:
  • 0: No granules
  • 1+: Few scattered granules
  • 2+: Moderate granules
  • 3+: Heavy granule staining
  • 4+: Dense, confluent granules
Diagnostic threshold for AML: ≥3% of blasts MPO positive (WHO 2022 and FAB classification criterion)
Auer rods: Contain MPO; appear as MPO-positive rod-shaped inclusions in AML blasts - pathognomonic.

Clinical Applications

  1. AML vs. ALL: Most important use; MPO+ = AML (myeloid lineage); MPO- = ALL or non-myeloid
  2. AML subtyping:
    • M1 (minimally differentiated myeloid): MPO+ in ≥3% blasts
    • M2 (AML with maturation): MPO strongly positive
    • M3 (APL): MPO extremely strongly positive (hypergranular promyelocytes)
    • M4 (myelomonocytic): MPO+ (neutrophilic component); NSE+ (monocytic component)
    • M5 (monocytic): MPO weak/negative; NSE+++
  3. Blast crisis of CML: MPO helps confirm myeloid blast crisis vs. lymphoid
  4. Myeloid sarcoma: Confirms myeloid nature of extramedullary mass
  5. Bone marrow failure states: Identifies residual myeloid cells

Limitations

  • False negative MPO:
    • Prolonged storage of slides (MPO degrades)
    • Hot fixation (heat destroys MPO)
    • Wrong fixative
    • Some M5 (monocytic) AML = MPO negative (use NSE instead)
    • M7 (megakaryoblastic) and ALL = both MPO negative
  • False positive:
    • Eosinophil peroxidase (not MPO) - eosinophils always stain
    • Benzidine is carcinogenic (lab hazard); modern labs use DAB or other safer chromogens
  • Cannot distinguish M5 from ALL (both MPO negative) - need NSE, CD3, CD20 by IHC/flow cytometry

MPO Detection by Flow Cytometry

Principle

Cells are permeabilized (to allow antibody entry into cytoplasm), then incubated with anti-MPO monoclonal antibody conjugated to a fluorochrome. Flow cytometer detects fluorescence intensity per cell.

Advantages over Cytochemical MPO

FeatureCytochemical MPOFlow Cytometry MPO
Sensitivity~70-80% (misses some M5)>95%
SpecificityHighHigh
Speed2-4 hours3-6 hours
ObjectivitySubjective scoringObjective (% positive cells)
Multi-parameterNo (single stain)Yes (can combine with 8-12 markers simultaneously)
Detects lineage switchLimitedExcellent
CostLowHigher
EquipmentBasic microscopeFlow cytometer required
Flow cytometric MPO is now the standard in acute leukemia immunophenotyping (along with CD13, CD33, CD117, HLA-DR for myeloid; CD3, CD19, TdT for lymphoid) per WHO and ELN guidelines.

Q11. Platelet Counting

Manual Platelet Count

Methods

A. Indirect Method (Estimation from Blood Smear)
  • Count platelets per 100 RBCs in the monolayer zone; multiply by RBC count/µL / 100
  • OR: Average number of platelets per oil immersion field × 15,000 = platelet count/µL
  • Rough estimate only; not for clinical decisions
B. Direct Method (Hemocytometer)
Rees-Ecker Method:
  • Diluting fluid: Rees-Ecker fluid = sodium citrate 3.8 g + brilliant cresyl blue 0.1 g + formalin 40% (0.2 mL) + distilled water to 100 mL
  • Formal citrate acts as anticoagulant + platelet fixative
  • BCB stains platelets pale blue
Ammonium oxalate method (preferred):
  • Diluting fluid: 1% ammonium oxalate solution
  • Lyses RBCs selectively (osmotic); WBCs lyse slowly; platelets preserved
  • Cleaner preparation than Rees-Ecker
Procedure (Improved Neubauer, Phase Contrast):
  1. Mix blood; add 0.02 mL to 0.38 mL diluting fluid (1:20 dilution)
  2. Charge the hemocytometer with a clean cover glass
  3. Place in a humid chamber for 20-30 minutes (allows platelets to settle)
  4. Count under phase contrast microscopy (40×): Platelets appear as small, bright, refractive discs
  5. Count platelets in central large square (1 mm²) = 25 small squares in both chambers = 50 small squares
Calculation:
  • Volume of 25 small squares = 25 × (0.2 mm × 0.2 mm × 0.1 mm) = 0.1 mm³
  • Platelets/µL = (Platelets in 25 squares × 20) / 0.1 = Platelets in 25 squares × 200
  • If counting 50 squares (both chambers): Platelets/µL = Total × 100
Phase contrast microscopy is essential - platelets are nearly invisible under bright-field with Rees-Ecker fluid; phase contrast makes them distinct from debris.

Normal Range

  • Normal platelet count: 150-400 × 10⁹/L (150,000-400,000/µL)
  • Some sources: 150-450 × 10⁹/L

Automated Platelet Count

Impedance Method

  • Platelets (<30 fL) counted separately from RBCs (>36 fL) by cell volume threshold
  • Problem: Microcytes, RBC fragments, large platelets may be misclassified; giant platelets (>30 fL) may not be counted

Optical/Light Scatter Method

  • Platelet channel uses low-angle forward scatter to count and size platelets
  • Better discrimination of platelets from fragments/debris

Fluorescent Platelet Count (Sysmex XN PLT-F channel)

  • CD61 fluorescent antibody-based counting (or CD41 equivalent fluorescent dye)
  • Gold standard for accuracy in thrombocytopenic patients
  • Accurately counts even at very low levels (<10 × 10⁹/L)
  • Unaffected by fragments, microcytes, or large platelets

Platelet Parameters Generated by Automated Analyzers

ParameterAbbreviationNormalClinical Use
Platelet countPLT150-400 ×10⁹/LThrombocytopenia/thrombocytosis
Mean Platelet VolumeMPV7.5-12.5 fLYoung large platelets = active thrombopoiesis
Platelet Distribution WidthPDW9-17%Anisotropy of platelet size; high in ITP
PlateletcritPCT0.15-0.4%Platelet equivalent of hematocrit
Immature Platelet FractionIPF (also "reticulated platelets")1-7%% young RNA-containing platelets; rises in ITP/platelet destruction; low in aplastic anemia
Large Platelet CountP-LCR13-43%% platelets >12 fL

Causes of Thrombocytopenia (<150 × 10⁹/L)

Decreased Production

  • Aplastic anemia
  • Bone marrow infiltration (leukemia, myeloma, lymphoma, metastatic carcinoma)
  • Megaloblastic anemia (B12/folate deficiency)
  • Myelodysplastic syndrome
  • Viral infections (parvovirus B19, CMV, EBV, Hepatitis B/C, HIV)
  • Drugs (chemotherapy, thiazides, alcohol, valproate)
  • Radiation

Increased Destruction

  • Immune:
    • ITP (Immune Thrombocytopenic Purpura) - most common cause of isolated thrombocytopenia in outpatients
    • Drug-induced immune thrombocytopenia (heparin-induced = HIT, quinine, quinidine, sulfonamides)
    • Post-transfusion purpura
    • Neonatal alloimmune thrombocytopenia
    • SLE, APS
  • Non-immune (consumption):
    • DIC
    • TTP (Thrombotic Thrombocytopenic Purpura)
    • HUS (Hemolytic Uremic Syndrome)
    • HELLP syndrome (pregnancy)
    • Giant hemangioma (Kasabach-Merritt)

Sequestration / Distribution

  • Hypersplenism (splenomegaly from any cause - sequesters up to 90% of platelets)

Dilutional

  • Massive transfusion (stored blood has no viable platelets)

Causes of Thrombocytosis (>400 × 10⁹/L)

Reactive (Secondary)Clonal (Primary)
Iron deficiency anemiaEssential thrombocythemia (ET)
Post-splenectomyPolycythemia vera
Infection/inflammationCML
Post-surgery/traumaPrimary myelofibrosis
Malignancy
Rebound after thrombocytopenia
Reactive: PLT rarely >1000 × 10⁹/L; underlying cause present Clonal (ET, PV, CML): PLT may be >1000 × 10⁹/L; JAK2/MPL/CALR mutations

Pseudothrombocytopenia

Definition: Artificially low platelet count reported by automated analyzer in a sample with a true normal or high platelet count.
Causes:
  1. EDTA-induced platelet clumping (most common): EDTA activates cryptic platelet antibodies (IgG/IgM) that cause platelet aggregation at room temperature → clumps counted as single events or not counted → falsely low count
    • Solution: Repeat count on citrate tube or heparin tube, or warm the blood to 37°C before running
  2. Platelet satellitism: Platelets adhere around neutrophils → platelets counted with neutrophil = falsely low platelet count + falsely high neutrophil count
  3. Giant platelets: (Bernard-Soulier syndrome, MYH9 disorders, ET) - exceed the upper size threshold and are excluded from platelet count
  4. Fragmented RBCs/microcytes - counted as platelets → pseudothrombocytosis
Diagnosis of pseudothrombocytopenia:
  • Examine peripheral smear: platelet clumps visible
  • Repeat in citrate/heparin (no EDTA)
  • Platelet count returns to normal in alternative anticoagulant

Q12. Complete Routine Urine Examination

Urine Collection

  • Specimen: Midstream clean-catch urine (MSCCU); 10-30 mL
  • Container: Wide-mouthed, sterile, dry, clean, labeled container
  • Timing: First morning specimen preferred (concentrated; casts/cells better preserved)
  • Storage: Examine within 2 hours; if delayed, refrigerate at 4°C (up to 4-6 hours); chemical preservatives (boric acid, formalin) for selected tests
  • Avoid contamination from vaginal secretions, periurethral flora

A. Physical Examination

PropertyNormalAbnormal
Volume1000-1500 mL/24hPolyuria >2500 mL, Oliguria <400 mL, Anuria <100 mL
ColorPale yellow to amberColorless (polyuria, diabetes insipidus), dark yellow/orange (dehydration, bilirubin, rifampicin), red/pink (hematuria, hemoglobinuria, myoglobinuria, beets, porphyria), brown/black (severe hemolysis, metronidazole, melanin, homogentisic acid in alkaptonuria), green (Pseudomonas infection, amitriptyline, biliverdin), milky white (pyuria, chyluria, phosphaturia)
Appearance/ClarityClearCloudy (UTI, pyuria, phosphates/urates in standing urine), turbid, frothy
FrothinessNilPersistent froth = proteinuria (surface tension reduced by protein)
OdorFaintly aromaticAmmoniacal (UTI, old urine), fruity/sweet (ketones in DKA), offensive (fetor, infection), mousy (phenylketonuria)
Specific gravity (SG)1.003-1.030 (random)Fixed SG 1.010 = isosthenuria (renal tubular failure); SG >1.020 = concentrated; SG <1.005 = very dilute
Reaction (pH)4.5-8.0 (average 6.0)Acid (DKA, high-protein diet, starvation), alkaline (UTI with urea-splitting organisms, vomiting, metabolic alkalosis, vegetarian diet)

B. Chemical Examination (Reagent Strip Tests / Dipstick)

Modern reagent strips test up to 10 parameters simultaneously. Each pad on the strip contains specific reagents; color change is read visually or by automated strip reader.

1. Protein (Albustix)

Principle: Protein Error of Indicators - at a fixed buffer pH, proteins (mainly albumin) bind to the indicator dye (tetrabromophenol blue or bromocresol green), causing a color shift from yellow to green/blue at pH maintained constant. The color change reflects protein concentration (not pH change).
  • Normal: Nil to trace (<30 mg/dL or <150 mg/24h)
  • Dipstick detects albumin preferentially; does not detect Bence Jones protein (BJP), globulins, or tubular proteins well
  • Sensitivity: ~15-30 mg/dL albumin
  • False positives: Alkaline/concentrated urine, contamination with chlorhexidine, prolonged immersion, highly buffered urine
  • False negatives: Dilute urine, acidic urine, globulinuria (BJP)
  • Positive protein (≥1+): Nephropathy, nephrotic syndrome, UTI, cardiac failure; requires 24-hour protein quantification and further workup

2. Glucose (Clinitest / Glucostix)

Principle: Glucose oxidase-peroxidase (GOD-POD) method:
  1. Glucose oxidase oxidizes glucose → gluconic acid + H₂O₂
  2. Peroxidase uses H₂O₂ to oxidize a chromogen (tetramethylbenzidine/KI) → colored product
  • Normal: Negative (glucose <180 mg/dL in serum = below renal threshold)
  • Glycosuria: Blood glucose >180 mg/dL (renal threshold) in diabetes mellitus; also renal glycosuria (normal blood glucose but low tubular threshold - Fanconi syndrome)
  • False positives: Chlorine/hypochlorite contamination
  • False negatives: Ascorbic acid (vitamin C) competitively inhibits peroxidase → most important cause; highly specific for glucose (non-glucose reducing substances like galactose, fructose, lactose, pentoses are NOT detected by enzymatic strip)
  • Reducing substances test (Clinitest tablets - copper reduction): Detects ALL reducing substances including non-glucose sugars; useful in children for galactosemia, fructosuria

3. Ketones

Principle: Nitroprusside (sodium nitroprusside) reaction - ketone bodies (acetoacetate and acetone) react with nitroprusside in alkaline conditions to form a purple/violet color (Rothera's test principle).
  • Detects acetoacetate >5 mg/dL; also acetone (less sensitive); does NOT detect beta-hydroxybutyrate (predominant ketone in DKA)
  • Positive in: Diabetic ketoacidosis (DKA), starvation ketosis, low-carbohydrate diets, vomiting, fever in children
  • False positive: Mesna, captopril, levodopa

4. Blood / Hemoglobin

Principle: Pseudoperoxidase activity of hemoglobin (heme portion) catalyzes oxidation of a chromogen (tetramethylbenzidine or guaiac) by H₂O₂ → green/blue color.
Detects:
  • Hematuria: Intact RBCs → spot pattern (speckling on pad)
  • Hemoglobinuria: Free hemoglobin (hemolysis) → uniform color change
  • Myoglobinuria: Myoglobin also has pseudoperoxidase activity; positive result
  • False positives: Povidone-iodine (Betadine) contamination, bacterial peroxidases (UTI), menstrual contamination
  • False negatives: Ascorbic acid (most important), nitrite, high SG

5. Bilirubin

Principle: Diazonium salt reaction - bilirubin (conjugated/direct) reacts with a stabilized diazonium salt (2,6-dichlorobenzene diazonium tetrafluoroborate) in an acid medium → purple azo-dye.
  • Only conjugated bilirubin is filtered by glomerulus (water-soluble); direct bilirubin in urine = bilirubinuria
  • Positive in: Hepatocellular jaundice, obstructive (cholestatic) jaundice
  • Negative in: Hemolytic jaundice (unconjugated bilirubin not filtered)
  • False positives: Chlorpromazine, rifampicin (orange discoloration)
  • False negatives: Prolonged exposure to light (bilirubin photo-oxidized), ascorbic acid, nitrite

6. Urobilinogen

Principle: Ehrlich's aldehyde reaction - urobilinogen reacts with p-dimethylaminobenzaldehyde (PDMAB) in acid to form a pink-red Ehrlich's chromogen (or modified Ehrlich's reagent).
  • Normal: 0.1-1.0 Ehrlich units/dL (trace positive on dipstick is normal)
  • Increased (>1.0): Hemolytic anemia (increased RBC breakdown → more urobilinogen), hepatocellular disease (impaired conjugation → spillover to urine)
  • Absent/decreased: Complete biliary obstruction (no bile reaching gut → no urobilinogen formed), antibiotic therapy (kills gut flora that convert bilirubin to urobilinogen)
  • False positives: Porphobilinogen (reacts with Ehrlich's reagent), sulfonamides

7. Nitrites

Principle: Greiss reaction - nitrate in urine (from dietary sources) is reduced to nitrite by gram-negative bacteria that produce nitrate reductase. Nitrite reacts with an aromatic amine (p-arsanilic acid) → diazonium compound → couples with 1,2,3,4-tetrahydrobenzoquinoline → pink-red color.
  • Positive: Significant bacteriuria (>10⁵ organisms/mL) with gram-negative bacteria (E. coli, Klebsiella, Proteus, Enterobacter)
  • Negative/false negative: Gram-positive organisms (Staphylococcus, Enterococcus) lack nitrate reductase; dilute urine; ascorbic acid; urine not incubated in bladder for >4 hours

8. Leukocyte Esterase

Principle: Leukocyte (neutrophil) granules contain esterase enzyme. Esterase cleaves an ester substrate (indoxyl ester) → releases indoxyl → reacts with a diazonium salt → purple color.
  • Positive in: UTI, interstitial nephritis, sterile pyuria (TB, SLE, Chlamydia infection), contamination
  • Normal: Negative (≤5 WBCs/hpf)
  • False negative: Glycosuria (high glucose slows reaction), proteinuria (>3 g/L), high SG, tetracycline, cephalexin, gentamicin
  • Combined positive nitrite + LE = high sensitivity and specificity for UTI

9. Specific Gravity (Density Pad)

Principle: Ionic strength-sensitive pad: polyelectrolyte changes color with ionic concentration (indirect measurement). Multistix uses a pH indicator (bromthymol blue) that responds to ionic changes.

10. pH

Principle: Double-indicator system (methyl red + bromthymol blue); color changes from orange (pH 5) to yellow (pH 6) to blue-green (pH 7-8).

C. Microscopic Examination (Urine Sediment)

Preparation

  1. Mix urine well; pour 10 mL into conical centrifuge tube
  2. Centrifuge at 1500 rpm for 5 minutes (400-500 × g; high speed destroys casts)
  3. Decant supernatant; leave ~0.5-1 mL deposit
  4. Resuspend deposit gently; place a drop on glass slide; cover with coverslip
  5. Examine: Low power (10×) for overview and casts; High power (40×) for cells, bacteria

Normal Findings

  • RBCs: 0-3/hpf
  • WBCs: 0-5/hpf
  • Epithelial cells: Occasional
  • Casts: 0-2 hyaline casts/lpf
  • Bacteria: Nil (fresh, MSCCU)
  • Crystals: Variable (clinically relevant only if pathological type)

Cells

CellSignificance
RBCs (>5/hpf = hematuria)Dysmorphic/acanthocytic RBCs = glomerular origin (GN); Isomorphic (normal shape) = lower urinary tract (cystitis, tumor, stones)
WBCs/Pus cells (>5/hpf = pyuria)UTI, pyelonephritis, interstitial nephritis; sterile pyuria: TB (always AFB in sterile pyuria), SLE, Chlamydia
Renal tubular epithelial cells (RTE)Acute tubular necrosis, viral nephritis, drug nephrotoxicity
Squamous epithelial cellsNormal vaginal contamination; presence in MSC sample = contamination
Transitional (urothelial) cellsNormal shedding; large numbers/clusters suggest TCC of bladder
Eosinophils (Hansel's stain)Drug-induced interstitial nephritis (hypersensitivity)

Casts

Casts are cylindrical molds of the renal tubular lumen, formed when protein (Tamm-Horsfall mucoprotein/uromodulin) or cells gel in the tubular lumen. Cast formation is favored by: acidic pH, high concentration, stasis.
Cast TypeCompositionSignificance
HyalinePure proteinNormal in small numbers; concentrated urine, exercise, fever
GranularCellular debris + proteinNon-specific; degeneration of cellular casts; renal disease
Red cell (RBC)RBCs embedded in proteinPathognomonic of glomerulonephritis (any form)
White cell (WBC)WBCs in proteinPyelonephritis, acute interstitial nephritis
Renal tubular cellRTE cells in proteinATN, toxic nephropathy, viral nephritis
Waxy/broadDegenerated granular casts; wide = collecting ductChronic renal failure, end-stage kidney disease
FattyLipid droplets (maltese cross under polarized light)Nephrotic syndrome, lipiduria
PigmentedHemoglobin/myoglobinHemoglobinuria/myoglobinuria
BacterialBacteria in matrixPyelonephritis

Crystals

CrystalAppearanceSignificance
Uric acidYellow/brown rhombs, rosettesGout, hyperuricemia, uric acid nephrolithiasis
Calcium oxalateEnvelope (dihydrate) or dumbbell (monohydrate)Normal or oxalate stones; ethylene glycol poisoning (calcium oxalate monohydrate)
Triple phosphate (struvite)"Coffin-lid" prismsUTI with urea-splitting bacteria (Proteus); staghorn calculi
CystineHexagonal platesCystinuria (always significant)
CholesterolNotched rectangular platesNephrotic syndrome, chyluria
Leucine/TyrosineYellow spheres/needlesSevere hepatic disease
BilirubinYellow granules/needlesBilirubinuria, liver disease

Organisms

  • Bacteria (rod or cocci): UTI (require culture + sensitivity)
  • Yeast (Candida): UTI in diabetics, immunocompromised, indwelling catheter
  • Trichomonas vaginalis: Motile flagellated protozoa; contamination or vaginal trichomoniasis

D. Automated Urine Analyzers

1. Reflectance Photometry (Strip Readers)

  • Urine Dipstick Reader: Clinitek (Siemens), Urinalyzer (Arkray), Aution Max
  • Standardized reflectance reading of dipstick pads; eliminates reader subjectivity
  • Reports: LE, nitrite, protein, glucose, pH, blood, bilirubin, urobilinogen, SG, ketones, creatinine
  • IQ200/IRIS system: Combines reflectance + digital microscopy

2. Automated Urine Microscopy Analyzers

Sysmex UF-5000 / UF-4000:
  • Uses fluorescent dyes (to label DNA, RNA, cell membranes) + laser light scatter
  • 5 populations identified: RBCs, WBCs, epithelial cells, bacteria, casts, yeast
  • Results in <90 seconds per sample
  • Flags samples for manual review if abnormal populations detected
IRIS iQ200:
  • Bright-field and/or phase contrast digital imaging
  • Automated particle classification by machine learning
  • Reports: RBCs (dysmorphic vs. isomorphic), WBCs, epithelial cells, casts (typed), bacteria, crystals, yeast
  • High-resolution images stored for review
CenSlide 2000: Continuous flow imaging

3. Automated Urine Chemistry Analyzers

  • Aution Max AX-4280 (Arkray)
  • Clinitek Atlas (Siemens)
  • Rapid results; reduces manual reading errors; throughput: 200-500 samples/hour

Advantages of Automated Urine Analysis

  • Eliminates observer bias
  • Standardized reporting
  • High throughput
  • Digital image archive
  • Reduces manual microscopy workload (only abnormal flagged samples reviewed manually)
  • Better detection of dysmorphic RBCs for glomerulonephritis screening

Summary - Clinical Significance Patterns

PatternLikely Condition
Protein+, RBC casts, dysmorphic RBCs, hematuriaGlomerulonephritis
Protein++ or +++, fatty casts, lipiduriaNephrotic syndrome
WBC casts, pyuria, bacteriuria, nitrite+Pyelonephritis
Glucose+, ketones+, pH acidDKA
RBC casts absent, hematuria, normal proteinLower UTI, renal calculus, tumor
Fixed SG, waxy broad casts, protein+Chronic renal failure
Sterile pyuria, no organisms on cultureRenal TB (AFB culture required)
Cystine crystalsCystinuria

References: Dacie & Lewis Practical Haematology (12th ed.), Wintrobe's Clinical Hematology (13th ed.), Henry's Clinical Diagnosis and Management by Laboratory Methods (23rd ed.), Tietz Textbook of Laboratory Medicine (7th ed.), WHO Manual on Diagnosis of Anaemia, ICSH guidelines, Cheesbrough District Laboratory Practice in Tropical Countries.
This is a shared conversation. Sign in to Orris to start your own chat.